glp 1 announcement today Pres. Donald Trump announced that starting July 1, 2026, Medicare patients will be able to access GLP-1 weight-loss medications such as Ozempic for a $50 monthly copay through a new short-term Centers New legislation would lower cost

A lifeline These clinics and technicians provide an essential lifeline for so many who are dragging themselves around trying to survive on one injection every three months whilst trying to function, keep their mental health on track, look after a family, hold down a job and who may have had to home school on top of everything else during this years lockdowns

If, however, someone is regularly juicing vegetables or consuming large quantities of vegetables high in beta-carotene (in addition to taking the CellSentials), it may be possible to develop hypercarotenemia

The logic behind this is simple: if you experience mild nausea or dizziness shortly after the injection, you might be able to sleep through the most uncomfortable part

Benefit leaders are fielding questions, juggling budgets, and working to clarify why plans look different this year

Wegovy for cardiovascular disease and Zepbound for sleep apnea continue to be covered separately